Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$7 $273,000,000 based on 39 million shares outstanding
Probably, just like it never left the OTC.
Could this be a reversal, 1000% pure speculating, based on chart
I wonder about this company
How shitty can a shit stock get?
I thought you sold your Share. You concerned about price ALL TIME LOW ?
Who cares About Price they Don’t
Read the filings. It isn't a joke, pal
lol. That’s a good one!!! Keep them coming…it’s entertaining:)
lol. That’s a good one!!! Keep them coming…it’s entertaining:)
Another 30-40K shares dumped at an ATL.
Only The Company or 3rd party offshore diluters or institutions would be selling.
And likely not the latter. The company needs cash because they are nearing bankruptcy
It's probably going to reverse split.
It perhaps is, because AEGIS initiated the filing, and the accelerated requests and were denied. They are a rather large company, but they also are shady. Slilaty tried to push it through 2 more times, and was also denied. There's also their share buyback, that ends in a little over a month. They didn't buy that much while diluting at the same time.
Nora seems to act like a company I'd invest in. They have revenue, have generics in distribution, and in the pipeline. SBFM literally has nothing but all the cash they received from fundraising.
A lot of companies in this tier get the same response on form 4’s. It shouldn’t be surprising.
A lot of companies in this tier get the same response on form 4’s. It shouldn’t be surprising.
There is no way to trade the OTC on fundamentals or charts. I hope for people who didn’t dump that Nora turns into something stable.
They weren’t the only ones!
Everyone was at home not spending money and some if not more getting stimulus money. I joined the game late. But for two years it was like shooting fish in a barrel in the OTC. Just learn from mistakes and don’t trade on emotion. Easier said than done.
The market went wild for SBFM in 2020. However, they never changed one bit and never had anything. This is unfortunate and similar to CytoDyn, which the SEC busted for near identical claims and PRs. This is why you can get bet the SEC has eyes on Sunshine. They are already pissed at them if you read their filings.
Have you ever seen a filing where an SEC Official literally said "Stop sending us your Form 4's, we will not even look at them." They were all denied for the SBFM Executives & AEGIS because of their high rate of abuse and dilution.
You can find it all in their SEC archives. And since they can't directly dump shares, they do it through 3rd parties, a private selling stock holder who suddenly has 18M shares, and private offshore placement...
Every day someone is dumping tens of thousands, maybe hundreds of thousands of shares because Sunshine raised their O/S to an ungodly level (an additional 18M when it was already around 23M) so they can continue their scam of a pharmaceutical business.
Nora at least seems to be doing well.
Seems as though some lost a high percentage of their money. I hope everyone learns that these stocks are a lottery ticket. Look at the OTC like a casino only bring what you can lose.
It was never billions but valued at such of adva-27a went to market.
They based this off prior failed studies and received the same results time and time again without modification to the drug.
This is misleading and deception.
A while back thought billion billions market capitalization , probably won’t happen
This could be considered fraudulent because it isn't SBFMs first attempt at trials with adva-27a.
Knowingly misleading people after prior testing and doing so repeatedly with adva-27a and lab rats is fraud.
Also, knowing you are upping the price based on faulty results is also fraud.
When did they know again for the 4th time? That analyst bumped up the price from $2.60 and then to $3 quite recently!
I am sure Sunshine gets progress reports.
I was thinking he would have to lower the price target since I recall the analysis included some progress with Adva-27a, which apparently won't happen anytime soon based on "pausing" the IND-enabling study at JGH.
The guy who did that is literally ranked #8000 out of #8100 analysts. He's the type you bet against.
He upped it once already, from $2.60 to $3.00 within 1 year. Maybe he is including the post spit price.
Perhaps AEGIS will update their BUY rating and 1 year price target to reflect this new development regarding Adva-27a. I'm curious where they stand with the latest news.
Nora Phar Only thing going for
Followers
|
760
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113765
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |